Item 9 Labs Corp
OTC:INLB
Item 9 Labs Corp
OTC:INLB
Price:
0.0001
USD
Market Cap:
$701.8
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Item 9 Labs Corp
OTC:INLB
|
US |
|
Eastech Holding Ltd
TWSE:5225
|
TW |
|
Atlas Pearls Ltd
ASX:ATP
|
AU |
|
S
|
Suzhou Douson Drilling&Production Equipment Co Ltd
SSE:603800
|
CN |
|
OKE Precision Cutting Tools Co Ltd
SSE:688308
|
CN |
|
Envipro Holdings Inc
TSE:5698
|
JP |
Balance Sheet
Balance Sheet Decomposition
Item 9 Labs Corp
Item 9 Labs Corp
Balance Sheet Decomposition is not available for
Item 9 Labs Corp
Item 9 Labs Corp
Balance Sheet
Item 9 Labs Corp
Item 9 Labs Corp
Currency: USD
| Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
3
|
2
|
7
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
0
|
3
|
3
|
3
|
10
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
7
|
7
|
11
|
22
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
7
|
7
|
11
|
22
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
2
|
8
|
19
|
12
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
58
|
58
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
18
|
8
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
8
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
58
|
58
|
|
| Total Assets |
1
N/A
|
0
-61%
|
1
+15%
|
0
-78%
|
5
+4 375%
|
14
+187%
|
21
+43%
|
117
+465%
|
111
-5%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
2
|
2
|
2
|
1
|
1
|
2
|
4
|
6
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
4
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
1
|
0
|
0
|
3
|
5
|
5
|
16
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Total Current Liabilities |
3
|
2
|
3
|
2
|
1
|
7
|
10
|
15
|
41
|
|
| Long-Term Debt |
0
|
0
|
0
|
3
|
2
|
0
|
2
|
15
|
7
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Liabilities |
4
N/A
|
3
-5%
|
3
-7%
|
5
+62%
|
2
-51%
|
7
+183%
|
13
+80%
|
31
+143%
|
49
+59%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
12
|
15
|
32
|
37
|
1
|
11
|
23
|
34
|
65
|
|
| Additional Paid In Capital |
9
|
12
|
29
|
32
|
3
|
18
|
44
|
133
|
140
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
|
| Total Equity |
2
N/A
|
3
-22%
|
3
+10%
|
5
-89%
|
3
N/A
|
7
+191%
|
8
+7%
|
86
+974%
|
62
-28%
|
|
| Total Liabilities & Equity |
1
N/A
|
0
-61%
|
1
+15%
|
0
-78%
|
5
+4 375%
|
14
+187%
|
21
+43%
|
117
+465%
|
111
-5%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
2
|
2
|
3
|
4
|
55
|
64
|
56
|
95
|
98
|
|
Switch to:
Switch to:
See Also
Discover More
